| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $123.57 | $24.52 | 404.00% | 233.15x | 211.81x | 15.67x | 18.93x | 1.81x | $106.92M | 0.82% | $705.78M | 6.70 | $13.26B | 1,689.75 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $240.08 | $94.52 | 153.99% | 39.36x | 33.14x | 6.68x | 23.72x | 1.20x | $793.95M | 2.48% | $1.35B | 10.14 | $33.40B | 28.32 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $24.86 | $8.30 | 199.61% | 118.38x | 154.51x | 6.99x | 14.17x | 1.10x | $39.15M | 1.21% | $220.58M | 1.69 | $3.20B | 70.59 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $80.20 | $16.41 | 388.77% | 74.95x | 63.70x | 7.40x | 9.57x | 2.32x | $182.84M | 2.94% | $654.15M | 8.43 | $6.09B | 50.78 | ||
| HALO | HALOZYME THERAPEUTICS INC | $109.32 | $70.81 | 54.38% | 30.71x | 13.17x | 7.71x | 86.44x | 0.66x | $806.22M | 6.29% | $143.54M | 1.22 | $14.39B | 20.03 | ||
| KRYS | KRYSTAL BIOTECH INC | $356.19 | $86.28 | 312.83% | 43.07x | 46.71x | 23.88x | 7.76x | 2.54x | $257.78M | 2.45% | $1.36B | 46.03 | $10.12B | 43.40 | ||
| ADMA | ADMA BIOLOGICS INC | $9.72 | $8.73 | 11.38% | 13.50x | 11.59x | 4.33x | 5.33x | 0.61x | $116.47M | 5.25% | $408.21M | 1.79 | $2.24B | 9.61 | ||
| VCEL | VERICEL CORP | $43.22 | $8.88 | 386.61% | 90.04x | 89.65x | 7.21x | 5.98x | 2.13x | $61.66M | 2.79% | $370.04M | 7.25 | $2.18B | 49.50 | ||
| RPRX | ROYALTY PHARMA PLC | $62.07 | $38.48 | 61.32% | 33.02x | 11.57x | 10.89x | 3.65x | 0.68x | $2.92B | 10.58% | $9.79B | 21.99 | $43.84B | 37.28 | ||
| TGTX | TG THERAPEUTICS INC | $55.42 | $23.83 | 132.56% | 17.99x | 39.33x | 9.83x | 14.04x | 2.11x | $17.39M | 0.22% | $604.08M | 4.26 | $8.75B | 62.86 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.04 | $9.43 | 27.62% | 12.67x | 11.63x | 5.23x | 3.28x | 0.82x | $82.01M | 11.51% | $217.65M | 3.68 | $571.16M | 7.39 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $66.12 | $21.21 | 211.67% | 174.00x | 17.80x | 3.75x | 2.02x | 1.09x | $738.18M | 5.77% | $6.32B | 32.68 | $16.11B | 41.77 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.27 | $2.24 | 46.29% | 16.35x | 14.14x | 2.01x | 3.14x | 0.85x | $5.67M | 2.20% | $82.53M | 1.04 | $194.33M | 10.40 | ||
| TECH | BIO-TECHNE CORP | $72.33 | $17.38 | 316.09% | 61.82x | 34.67x | 9.28x | 5.38x | 2.01x | $263.22M | 2.33% | $2.11B | 13.52 | $11.37B | 32.70 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $552.85 | $156.84 | 252.50% | 31.90x | 28.59x | 11.14x | 6.92x | 2.52x | $3.80B | 2.71% | $20.25B | 79.81 | $135.96B | 24.71 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $281.72 | $93.30 | 201.94% | 27.98x | 30.49x | 19.45x | 5.80x | 2.10x | $130.62M | 2.31% | $967.52M | 48.22 | $5.74B | 20.58 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.23 | $6.43 | -80.88% | 8.79x | -4.16x | 1.52x | 1.62x | 0.07x | $19.58M | 27.48% | $44.20M | 0.76 | $22.90M | 3.00 | ||
| EXEL | EXELIXIS INC | $56.72 | $28.38 | 99.87% | 17.24x | 17.63x | 5.84x | 7.62x | 1.52x | $1.17B | 8.24% | $1.84B | 7.35 | $13.94B | 12.81 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $260.23 | $194.62 | 33.71% | 17.05x | 10.08x | 3.57x | 3.52x | 0.70x | $1.62B | 9.85% | $4.80B | 75.98 | $19.67B | 12.17 | ||
| MDXG | MIMEDX GROUP INC | $4.34 | $1.11 | 292.51% | 108.50x | -38.68x | 1.81x | 2.93x | 1.53x | $44.50M | 6.94% | $216.00M | 1.46 | $513.97M | 22.53 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $833.56 | $414.18 | 101.26% | 19.88x | 17.85x | 5.52x | 2.71x | 1.30x | $3.76B | 4.39% | $31.71B | 308.48 | $86.07B | 14.97 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.95 | $32.74 | 18.97% | 12.40x | 10.26x | 2.35x | 2.27x | 0.73x | $354.90M | 15.73% | $999.24M | 17.25 | $1.87B | 6.69 | ||
| UTHR | UNITED THERAPEUTICS CORP | $518.53 | $223.17 | 132.35% | 17.15x | 18.95x | 7.00x | 3.47x | 2.31x | $1.09B | 4.95% | $6.40B | 150.24 | $20.44B | 12.19 | ||
| INCY | INCYTE CORP | $129.72 | $60.07 | 115.95% | 15.98x | 17.07x | 4.47x | 4.14x | 2.14x | $1.92B | 7.39% | $6.34B | 31.66 | $22.34B | 10.80 |